Nitrite reductase is critical for Pseudomonas aeruginosa survival during co-infection with the oral commensal Streptococcus parasanguinis

Microbiology (United Kingdom)

Volumn 162, Issue 2, 2016, Pages 376-383

  Scoffield, Jessica A ^a   Wu, Hui ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; NITRITE REDUCTASE; NITRITE;

ARTICLE; BACTERIAL SURVIVAL; DROSOPHILA MELANOGASTER; ENZYME INACTIVATION; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PARASANGUINIS; SURVIVAL RATE; ANIMAL; COCULTURE; CYSTIC FIBROSIS; DEFICIENCY; GENETICS; METABOLISM; MICROBIOLOGY; PSEUDOMONAS INFECTION; STREPTOCOCCUS; STREPTOCOCCUS INFECTION;

ANIMALS; COCULTURE TECHNIQUES; COINFECTION; CYSTIC FIBROSIS; DROSOPHILA MELANOGASTER; NITRITE REDUCTASES; NITRITES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

EID: 85017081345     PISSN: 13500872     EISSN: 14652080     Source Type: Journal    
DOI: 10.1099/mic.0.000226     Document Type: Article

References (32)

1. Akhtar, S., Khan, A., Sohaskey, C. D., Jagannath, C. & Sarkar, D. (2013). Nitrite reductase NirBD is induced and plays an important role during in vitro dormancy of Mycobacterium tuberculosis. J Bacteriol 195, 4592–4599.
2. Carmeli, Y., Troillet, N., Eliopoulos, G. M. & Samore, M. H. (1999). Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 43, 1379–1382.
3. Cole, R. M., Calandra, G. B., Huff, E. & Nugent, K. M. (1976). Attributes of potential utility in differentiating among ‘‘group H’’ streptococci or Streptococcus sanguis. J Dent Res 55 (Suppl), A142–A153.
4. de la Fuente-Núñez, C., Reffuveille, F., Fairfull-Smith, K. E. & Hancock, R. E. (2013). Effect of nitroxides on swarming motility and biofilm formation, multicellular behaviors in Pseudomonas aeruginosa. Antimicrob Agents Chemother 57, 4877–4881.
5. Doel, J. J., Hector, M. P., Amirtham, C. V., Al-Anzan, L. A., Benjamin, N. & Allaker, R. P. (2004). Protective effect of salivary nitrate and microbial nitrate reductase activity against caries. Eur J Oral Sci 112, 424–428.
6. Filkins, L. M., Hampton, T. H., Gifford, A. H., Gross, M. J., Hogan, D. A., Sogin, M. L., Morrison, H. G., Paster, B. J. & O’Toole, G. A. (2012). Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability. J Bacteriol 194, 4709–4717.
7. Grasemann, H., Ioannidis, I., Tomkiewicz, R. P., de Groot, H., Rubin, B. K. & Ratjen, F. (1998). Nitric oxide metabolites in cystic fibrosis lung disease. Arch Dis Child 78, 49–53.
8. Hezel, M. P. & Weitzberg, E. (2015). The oral microbiome and nitric oxide homoeostasis. Oral Dis 21, 7–16.
9. Holloway, B. W., Krishnapillai, V. & Morgan, A. F. (1979). Chromosomal genetics of Pseudomonas. Microbiol Rev 43, 73–102.
10. Hyde, E. R., Andrade, F., Vaksman, Z., Parthasarathy, K., Jiang, H., Parthasarathy, D. K., Torregrossa, A. C., Tribble, G., Kaplan, H. B. & other authors (2014). Metagenomic analysis of nitrate-reducing bacteria in the oral cavity: implications for nitric oxide homeostasis. PLoS One 9, e88645.
11. Kolenbrander, P. E. & London, J. (1993). Adhere today, here tomorrow: oral bacterial adherence. J Bacteriol 175, 3247–3252.
12. Kreth, J., Zhang, Y. & Herzberg, M. C. (2008). Streptococcal antagonism in oral biofilms: Streptococcus sanguinis and Streptococcus gordonii interference with Streptococcus mutans. J Bacteriol 190, 4632–4640.
13. Lewis, J. P., Yanamandra, S. S. & Anaya-Bergman, C. (2012). HcpR of Porphyromonas gingivalis is required for growth under nitrosative stress and survival within host cells. Infect Immun 80, 3319–3331.
14. Liu, J., Wu, C., Huang, I. H., Merritt, J. & Qi, F. (2011). Differential response of Streptococcus mutans towards friend and foe in mixedspecies cultures. Microbiology 157, 2433–2444.
15. Maeda, Y., Elborn, J. S., Parkins, M. D., Reihill, J., Goldsmith, C. E., Coulter, W. A., Mason, C., Millar, B. C., Dooley, J. S. G. & other authors (2011). Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF). J Cyst Fibros 10, 133–139.
16. Majorana, A., Notarangelo, L. D., Savoldi, E., Gastaldi, G. & Lozada-Nur, F. (1999). Leukocyte adhesion deficiency in a child with severe oral involvement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87, 691–694.
17. Miller, J. H. (1972). Experiments in Molecular Genetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
18. Nobbs, A. H., Lamont, R. J. & Jenkinson, H. F. (2009). Streptococcus adherence and colonization. Microbiol Mol Biol Rev 73, 407–450.
19. Ohman, D. E. & Chakrabarty, A. M. (1981). Genetic mapping of chromosomal determinants for the production of the exopolysaccharide alginate in a Pseudomonas aeruginosa cystic fibrosis isolate. Infect Immun 33, 142–148.
20. Parkins, M. D., Sibley, C. D., Surette, M. G. & Rabin, H. R. (2008). The Streptococcus milleri group—an unrecognized cause of disease in cystic fibrosis: a case series and literature review. Pediatr Pulmonol 43, 490–497.
21. Peters, B. M., Jabra-Rizk, M. A., O’May, G. A., Costerton, J. W. & Shirtliff, M. E. (2012). Polymicrobial interactions: impact on pathogenesis and human disease. Clin Microbiol Rev 25, 193–213.
22. Ramsey, M. M. & Whiteley, M. (2009). Polymicrobial interactions stimulate resistance to host innate immunity through metabolite perception. Proc Natl Acad Sci U S A 106, 1578–1583.
23. Schweizer, H. D. (1993). Small broad-host-range gentamycin resistance gene cassettes for site-specific insertion and deletion mutagenesis. Biotechniques 15, 831–834.
24. Scoffield, J. A. & Wu, H. (2015). Oral streptococci and nitritemediated interference of Pseudomonas aeruginosa. Infect Immun 83, 101–107.
25. Sibley, C. D., Parkins, M. D., Rabin, H. R., Duan, K., Norgaard, J. C. & Surette, M. G. (2008). A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci U S A 105, 15070–15075.
26. Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P. & other authors (2006). Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103, 8487–8492.
27. Stacy, A., Everett, J., Jorth, P., Trivedi, U., Rumbaugh, K. P. & Whiteley, M. (2014). Bacterial fight-and-flight responses enhance virulence in a polymicrobial infection. Proc Natl Acad Sci U S A 111, 7819–7824.
28. Su, S., Panmanee, W., Wilson, J. J., Mahtani, H. K., Li, Q., Vanderwielen, B. D., Makris, T. M., Rogers, M., McDaniel, C. & other authors (2014). Catalase (KatA) plays a role in protection against anaerobic nitric oxide in Pseudomonas aeruginosa. PLoS One 9, e91813.
29. Suh, S. J., Silo-Suh, L. A. & Ohman, D. E. (2004). Development of tools for the genetic manipulation of Pseudomonas aeruginosa. J Microbiol Methods 58, 203–212.
30. Van Alst, N. E., Wellington, M., Clark, V. L., Haidaris, C. G. & Iglewski, B. H. (2009). Nitrite reductase NirS is required for type III secretion system expression and virulence in the human monocyte cell line THP-1 by Pseudomonas aeruginosa. Infect Immun 77, 4446–4454.
31. Whiley, R. A., Sheikh, N. P., Mushtaq, N., Hagi-Pavli, E., Personne, Y., Javaid, D. & Waite, R. D. (2014). Differential potentiation of the virulence of the Pseudomonas aeruginosa cystic fibrosis Liverpool epidemic strain by oral commensal streptococci. J Infect Dis 209, 769–780.
32. Whiley, R. A., Fleming, E. V., Makhija, R. & Waite, R. D. (2015). Environment and colonisation sequence are key parameters driving cooperation and competition between Pseudomonas aeruginosa cystic fibrosis strains and oral commensal streptococci. PLoS One 10, e0115513.